(Q36314909)

13 August 2017

1 reference

title

Drug-eluting stents: from evidence to policy (English)

1 reference

13 August 2017

Monia Marchetti

1

1 reference

13 August 2017

publication date

1 September 2004

1 reference

Expert Review of Medical Devices

13 August 2017

published in

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

49-63

1 reference

The great escape? Prospects for regulating access to technology through health technology assessment

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Transluminal dilatation of coronary-artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Management of patients undergoing percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Interventional cardiology in Europe 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Evidence for use of coronary stents. A hierarchical bayesian meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Prospects for cardiovascular research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

In-stent stenosis: pathology and implications for the development of drug eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Overcoming restenosis with sirolimus: from alphabet soup to clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Drug-eluting stents in vascular intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Drug-eluting stents: an early systematic review to inform policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Effects of stent length and lesion length on coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Vascular radiation in a drug-eluting stent world: it's not over till it's over

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Can we afford to eliminate restenosis? Can we afford not to?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Predicting vascular complications in percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

A break-even price calculation for the use of sirolimus-eluting stents in angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Drug eluting stents: maximising benefit and minimising cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Economic impact of drug-eluting stents on hospital systems: a disease-state model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Trends in clinical and economic outcomes of coronary angioplasty from 1992 to 1995: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Health technology diffusion rates. Statins, coronary stents, and MRI in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Practice of coronary angioplasty in California in 1995 : comparison to 1989 and impact of coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Is technological change in medicine worth it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

A paclitaxel-eluting stent for the prevention of coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Drug-eluting stents: costs versus clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Drug eluting stents: are human and animal studies comparable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Restenosis: the mouse that roared

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Acute and long-term cost implications of coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.1.1.49

21 January 2018

Identifiers

DOI

10.1586/17434440.1.1.49

1 reference

13 August 2017

1 reference